CLINICAL_TRIALS
trial_result
· 2020-09-18
Clinical Trial Update: Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine [Phase 4]
Summary
Phase 4 trial assessing immunogenicity and safety of the Japanese Encephalitis Vaccine when administered with the MMR vaccine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: PATH | Conditions: Encephalitis, Japanese, Measles | Phase 4 | Status: COMPLETED | Results posted: 2020-09-18